Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Carlos Ruiz-Cobo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Review of Anti-Infective Therapy|October 24, 2025
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis deltaJuan Carlos Ruiz-Cobo, Adriana Palom, Mar Riveiro-Barciela, et al.
Clinical and Molecular Hepatology|November 11, 2024
Hepatitis E as a trigger for acute-on-chronic liver failureMaria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 1, 2025
JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a SummerJuan Carlos Ruiz-Cobo, Lourdes Ruiz-Ortega, Virginia Robles-Alonso, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2026
Emergency Department Screening Reveals Declining HCV Viraemia but Stable HBV Prevalence in Western Europe: A Sentinel Surveillance OpportunityLena Vargas-Accarino, Murad Ruf, Liam Townsend, et al.
Clinical Kidney Journal|May 10, 2024
Acute kidney injury and point-of-care ultrasound in liver cirrhosis: redefining hepatorenal syndromeEduardo Josué Banegas-Deras, Jaime Mazón-Ruiz, Gregorio Romero-González, et al.
Journal of Viral Hepatitis|February 24, 2026
Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real-World Outcomes From the Adaptation of the NORA AppJudit Romero-Vico, Anna Feliu, Elena Vargas-Accarino, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective studyElena Vargas-Accarino, Ariadna Rando-Segura, Adriana Palom, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2025
Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary CareElena Vargas-Accarino, Ariadna Rando-Segura, María Asunción Úbeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registryMar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis eliminationJordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Review of Anti-Infective Therapy|October 24, 2025
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis deltaJuan Carlos Ruiz-Cobo, Adriana Palom, Mar Riveiro-Barciela, et al.
Clinical and Molecular Hepatology|November 11, 2024
Hepatitis E as a trigger for acute-on-chronic liver failureMaria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 1, 2025
JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a SummerJuan Carlos Ruiz-Cobo, Lourdes Ruiz-Ortega, Virginia Robles-Alonso, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 21, 2026
Emergency Department Screening Reveals Declining HCV Viraemia but Stable HBV Prevalence in Western Europe: A Sentinel Surveillance OpportunityLena Vargas-Accarino, Murad Ruf, Liam Townsend, et al.
Clinical Kidney Journal|May 10, 2024
Acute kidney injury and point-of-care ultrasound in liver cirrhosis: redefining hepatorenal syndromeEduardo Josué Banegas-Deras, Jaime Mazón-Ruiz, Gregorio Romero-González, et al.
Journal of Viral Hepatitis|February 24, 2026
Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real-World Outcomes From the Adaptation of the NORA AppJudit Romero-Vico, Anna Feliu, Elena Vargas-Accarino, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2024
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective studyElena Vargas-Accarino, Ariadna Rando-Segura, Adriana Palom, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2025
Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary CareElena Vargas-Accarino, Ariadna Rando-Segura, María Asunción Úbeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2024
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registryMar Riveiro-Barciela, Ana Barreira-Díaz, Paula Esteban, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis eliminationJordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, et al.
Pageof 2